GS

On the fundamental side, Goldman Sachs demonstrates robust financial health with a P/E ratio of 20.0 and a forward P/E of 18.6, suggesting that the stock is reasonably valued in relation to its earnings growth. The earnings per share (EPS) of $54.72 reflects a strong quarter-over-quarter growth rate of 24.2%. However, the year-over-year revenue growth shows a concerning decline of 138.4%, which raises red flags about sustainability. Despite this, the gross margin is extraordinarily high at 4,748.0%, and the operating margin is at 1,746.8%, indicating strong operational efficiency. Analyst consensus leans towards a HOLD with a target price of $951.30, reflecting mixed sentiment as many analysts see potential risks in the current valuation compared to the growth trajectory.

Upcoming earnings are scheduled for July 14, 2026, which is just within the 30-day window and will be critical for investor sentiment. The last quarter's performance on March 31, 2026, will set the stage for expectations moving forward, particularly in light of the unusual revenue decline. Notably, recent news highlights that Lee Johnson Capital Management LLC has lowered its stock position in Goldman Sachs, which may signal a lack of confidence among institutional investors. Investors should closely monitor the upcoming earnings report for any indications of revenue stabilization or further margin compression, as these factors will likely influence the stock's trajectory in the near term.